Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare the efficacy of rosuvastatin 10 mg with
atorvastatin 10 mg by assessment of the percentage of subjects who reach EAS LDL-C target
goals after 12 weeks of therapy.